Scientific article
OA Policy
English

Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction

Published in

Antioxidants & redox signaling, vol. 18, no. 6, p. 630-641

Publication date

2013

Abstract

Nicotinamide phosphoribosyltransferase (Nampt) is a key enzyme for nicotinamide adenine dinucleotide (NAD(+)) biosynthesis, and recent evidence indicates its role in inflammatory processes. Here, we investigated the potential effects of pharmacological Nampt inhibition with FK866 in a mouse myocardial ischemia/reperfusion model. In vivo and ex vivo mouse myocardial ischemia/reperfusion procedures were performed.

Keywords

  • Acrylamides/administration & dosage
  • Animals
  • Chemokine CXCL2/metabolism
  • Humans
  • Male
  • Mice
  • Myocardial Infarction/drug therapy/enzymology/pathology
  • Myocardial Reperfusion Injury/drug therapy/pathology
  • NAD/biosynthesis
  • Neutrophil Infiltration/drug effects
  • Nicotinamide Phosphoribosyltransferase/antagonists & inhibitors/metabolism
  • Oxidative Stress/drug effects
  • Piperidines/administration & dosage
  • Reactive Oxygen Species/metabolism
  • Signal Transduction

Citation (ISO format)

MONTECUCCO, Fabrizio et al. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. In: Antioxidants & redox signaling, 2013, vol. 18, n° 6, p. 630–641. doi: 10.1089/ars.2011.4487

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1523-0864
795views
853downloads

Technical informations

Creation

24/11/2014 15:48:00

First validation

24/11/2014 15:48:00

Update

23/01/2025 11:37:35

Status update

23/01/2025 11:37:35

Last indexation

23/01/2025 11:45:31
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated